Page last updated: 2024-10-24

negative regulation of endoplasmic reticulum calcium ion concentration

Definition

Target type: biologicalprocess

Any process that decreases the concentration of calcium ions in the endoplasmic reticulum. [GOC:mah]

The negative regulation of endoplasmic reticulum (ER) calcium ion concentration is a vital process in maintaining cellular homeostasis and ensuring proper functioning of the ER. This regulation involves a complex interplay of molecular mechanisms that control calcium influx, efflux, and storage within the ER lumen. Here's a detailed description:

**1. Calcium Influx:**

* **IP3 Receptor (IP3R) Channels:** IP3, a second messenger generated in response to various stimuli, binds to IP3R channels on the ER membrane. This binding triggers the opening of the channels, allowing calcium to flow from the ER lumen into the cytoplasm.
* **Ryanodine Receptor (RyR) Channels:** These channels are primarily found in muscle cells and are activated by calcium itself, leading to a positive feedback loop that can rapidly increase cytosolic calcium levels.
* **Store-Operated Calcium Entry (SOCE):** When ER calcium stores are depleted, STIM1 proteins on the ER membrane sense the low calcium levels and activate ORAI1 channels on the plasma membrane. This allows calcium to flow from the extracellular environment into the cytoplasm, replenishing the ER stores.

**2. Calcium Efflux:**

* **SERCA Pumps:** These pumps are ATP-dependent and actively transport calcium ions back into the ER lumen, against their concentration gradient. This process is crucial for maintaining the calcium gradient across the ER membrane.
* **Plasma Membrane Calcium ATPase (PMCA):** This pump expels calcium ions from the cytoplasm to the extracellular environment, further contributing to the regulation of cytosolic calcium levels.

**3. Calcium Storage:**

* **Calcium-Binding Proteins:** Proteins like calreticulin and calnexin bind to calcium within the ER lumen, helping to buffer the calcium concentration and prevent excessive fluctuations.

**4. Negative Regulation Mechanisms:**

* **Protein Kinase A (PKA):** PKA can phosphorylate IP3R channels, reducing their sensitivity to IP3 and decreasing calcium release from the ER.
* **Protein Kinase C (PKC):** PKC can phosphorylate and inhibit SERCA pumps, slowing down calcium re-uptake into the ER.
* **Calcium-Dependent Negative Feedback:** High cytosolic calcium levels can activate calcium-dependent phosphatases that dephosphorylate and inhibit IP3R channels, reducing calcium release from the ER.

**5. Importance:**

* **ER Stress Response:** Maintaining proper ER calcium levels is essential for the folding and trafficking of proteins within the ER. Disruptions in ER calcium homeostasis can trigger the unfolded protein response (UPR), a stress response pathway that can ultimately lead to cell death.
* **Muscle Contraction:** In muscle cells, the release of calcium from the ER triggers muscle contraction.
* **Signal Transduction:** Calcium ions are important signaling molecules involved in a wide range of cellular processes, including gene expression, cell division, and apoptosis.

**In summary, the negative regulation of ER calcium ion concentration is a complex process that involves multiple mechanisms to control calcium influx, efflux, and storage. This regulation is crucial for maintaining cellular homeostasis, preventing ER stress, and supporting various cellular functions.**'
"

Proteins (4)

ProteinDefinitionTaxonomy
Bcl-2 homologous antagonist/killerA Bcl-2 homologous antagonist/killer that is encoded in the genome of human. [PRO:WCB, UniProtKB:Q16611]Homo sapiens (human)
Apoptosis regulator BAX An apoptosis regulator BAX that is encoded in the genome of human. [PRO:SY, UniProtKB:Q07812]Homo sapiens (human)
Protein-glutamine gamma-glutamyltransferase 2A protein-glutamine gamma-glutamyltransferase 2 that is encoded in the genome of human. [PRO:DNx, UniProtKB:P21980]Homo sapiens (human)
Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 A sarcoplasmic/endoplasmic reticulum calcium ATPase 1 that is encoded in the genome of human. [PRO:DNx, UniProtKB:O14983]Homo sapiens (human)

Compounds (27)

CompoundDefinitionClassesRoles
chelerythrinechelerythrine : A benzophenanthridine alkaloid isolated from the root of Zanthoxylum simulans, Chelidonium majus L., and other Papaveraceae.benzophenanthridine alkaloid;
organic cation
antibacterial agent;
antineoplastic agent;
EC 2.7.11.13 (protein kinase C) inhibitor
1-(2-naphthalenyl)-3-[(phenylmethyl)-propan-2-ylamino]-1-propanoneZM39923: structure in first sourcenaphthalenes
beta-lapachonebeta-lapachone : A benzochromenone that is 3,4-dihydro-2H-benzo[h]chromene-5,6-dione substituted by geminal methyl groups at position 2. Isolated from Tabebuia avellanedae, it exhibits antineoplastic and anti-inflammatory activities.

beta-lapachone: antineoplastic inhibitor of reverse transcriptase, DNA topoisomerase, and DNA polymerase
benzochromenone;
orthoquinones
anti-inflammatory agent;
antineoplastic agent;
plant metabolite
vitamin k 3Vitamin K 3: A synthetic naphthoquinone without the isoprenoid side chain and biological activity, but can be converted to active vitamin K2, menaquinone, after alkylation in vivo.1,4-naphthoquinones;
vitamin K
angiogenesis inhibitor;
antineoplastic agent;
EC 3.4.22.69 (SARS coronavirus main proteinase) inhibitor;
human urinary metabolite;
nutraceutical
vorinostatvorinostat : A dicarboxylic acid diamide comprising suberic (octanedioic) acid coupled to aniline and hydroxylamine. A histone deacetylase inhibitor, it is marketed under the name Zolinza for the treatment of cutaneous T cell lymphoma (CTCL).

Vorinostat: A hydroxamic acid and anilide derivative that acts as a HISTONE DEACETYLASE inhibitor. It is used in the treatment of CUTANEOUS T-CELL LYMPHOMA and SEZARY SYNDROME.
dicarboxylic acid diamide;
hydroxamic acid
antineoplastic agent;
apoptosis inducer;
EC 3.5.1.98 (histone deacetylase) inhibitor
5-bromoisatinindolesanticoronaviral agent
isatintribulin: endogenous MONOAMINE OXIDASE inhibitory activity extractable into ethyl acetate found in brain and many mammalian tissues and fluids; ISATIN is a major component; produced in excess following alcohol withdrawal;indoledioneEC 1.4.3.4 (monoamine oxidase) inhibitor;
plant metabolite
indirubin
5-Chloro-1H-indole-2,3-dioneindolesanticoronaviral agent
5-iodoisatin5-iodoisatin: structure in first sourceindolesanticoronaviral agent
alexidine dihydrchloride
6-n-tridecylsalicylic acid6-n-tridecylsalicylic acid: structure given in first sourcehydroxybenzoic acid
isoindigotinisoindigotin: used in treatment of chronic granulocytic leukemia; structure given in first source
n-phenylacrylamideN-phenylacrylamide: structure in first source
nsc 953971,4-naphthoquinones
thapsigarginthapsigargin : An organic heterotricyclic compound that is a hexa-oxygenated 6,7-guaianolide isolated fron the roots of Thapsia garganica L., Apiaceae. A potent skin irritant, it is used in traditional medicine as a counter-irritant. Thapsigargin inhibits Ca(2+)-transporting ATPase mediated uptake of calcium ions into sarcoplasmic reticulum and is used in experimentation examining the impacts of increasing cytosolic calcium concentrations.

Thapsigargin: A sesquiterpene lactone found in roots of THAPSIA. It inhibits SARCOPLASMIC RETICULUM CALCIUM-TRANSPORTING ATPASES.
butyrate ester;
organic heterotricyclic compound;
sesquiterpene lactone
calcium channel blocker;
EC 3.6.3.8 (Ca(2+)-transporting ATPase) inhibitor
ag-213tyrphostin 47: inhibits protein-tyrosine kinase activity of EGF-R both in vitro and in living cells;
5,6-dehydrokawain5,6-dehydrokawain: from Alpinia speciosa rhizoma; RN given for cpd without isomeric designation; structure given in first source2-pyranones;
aromatic ether
rottlerinrottlerin : A chromenol that is 2,2-dimethyl-2H-chromene substituted by hydroxy groups at positions 5 and 7, a 3-acetyl-2,4,6-trihydroxy-5-methylbenzyl group at position 6 and a (1E)-3-oxo-1-phenylprop-1-en-3-yl group at position 8. A potassium channel opener, it is isolated from Mallotus philippensis.

rottlerin: an angiogenesis inhibitor; an inhibitor of protein kinase Cdelta (PKCdelta) and calmodulin kinase III; RN refers to (E)-isomer; do not confuse this chalcone with an anthraquinone that is also called rottlerin (RN 481-72-1);
aromatic ketone;
benzenetriol;
chromenol;
enone;
methyl ketone
anti-allergic agent;
antihypertensive agent;
antineoplastic agent;
apoptosis inducer;
K-ATP channel agonist;
metabolite
gw-5074
abt-737aromatic amine;
aryl sulfide;
biphenyls;
C-nitro compound;
monochlorobenzenes;
N-arylpiperazine;
N-sulfonylcarboxamide;
secondary amino compound;
tertiary amino compound
anti-allergic agent;
anti-inflammatory agent;
antineoplastic agent;
apoptosis inducer;
B-cell lymphoma 2 inhibitor
meiogynin ameiogynin A: from the bark of Meiogyne cylindrocarpa; structure in first source
biselyngbyasidebiselyngbyaside: antineoplastic from the marine cyanobacterium Lyngbya sp.; structure in first source
jy-1-106JY-1-106: a BH3 alpha-helix mimetic that functions as a pan-Bcl-2 inhibitor; structure in first source
glutaminase
guanylyl imidodiphosphateguanosine 5'-[beta,gamma-imido]triphosphate : A nucleoside triphosphate analogue that is GTP in which the oxygen atom bridging the beta- to the gamma- phosphate is replaced by a nitrogen atom A non-hydrolyzable analog of GTP, it binds tightly to G-protein in the presence of Mg(2+).

Guanylyl Imidodiphosphate: A non-hydrolyzable analog of GTP, in which the oxygen atom bridging the beta to the gamma phosphate is replaced by a nitrogen atom. It binds tightly to G-protein in the presence of Mg2+. The nucleotide is a potent stimulator of ADENYLYL CYCLASES.
nucleoside triphosphate analogue
alpha-cyclopiazonic acidalpha-cyclopiazonic acids